vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $43.2M, roughly 1.4× ADAMAS TRUST, INC.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -70.9%, a 194.9% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs 8.1%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $-1.8M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
ADAM vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $62.1M |
| Net Profit | $53.5M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | — | -9.0% |
| Net Margin | 124.0% | -70.9% |
| Revenue YoY | 61.6% | 8.1% |
| Net Profit YoY | 270.5% | -557.1% |
| EPS (diluted) | $0.45 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | $62.1M | ||
| Q3 25 | $36.6M | $52.3M | ||
| Q2 25 | $36.4M | $45.6M | ||
| Q1 25 | $33.1M | $41.5M | ||
| Q4 24 | $26.7M | $57.5M | ||
| Q3 24 | $20.2M | $51.5M | ||
| Q2 24 | $19.0M | $46.6M | ||
| Q1 24 | $17.9M | $44.9M |
| Q4 25 | $53.5M | $-44.1M | ||
| Q3 25 | $44.8M | $-5.5M | ||
| Q2 25 | $8.5M | $-5.6M | ||
| Q1 25 | $42.2M | $-11.4M | ||
| Q4 24 | $-31.4M | $9.6M | ||
| Q3 24 | $42.8M | $941.0K | ||
| Q2 24 | $-15.6M | $-10.4M | ||
| Q1 24 | $-57.9M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | — | -17.6% | ||
| Q2 25 | 11.7% | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | -119.0% | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | -124.7% | -18.3% | ||
| Q1 24 | -448.8% | -23.9% |
| Q4 25 | 124.0% | -70.9% | ||
| Q3 25 | 122.5% | -10.5% | ||
| Q2 25 | 23.4% | -12.2% | ||
| Q1 25 | 127.4% | -27.5% | ||
| Q4 24 | -117.5% | 16.8% | ||
| Q3 24 | 211.7% | 1.8% | ||
| Q2 24 | -81.9% | -22.4% | ||
| Q1 24 | -324.1% | -13.8% |
| Q4 25 | $0.45 | — | ||
| Q3 25 | $0.36 | — | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $0.33 | — | ||
| Q4 24 | $-0.46 | — | ||
| Q3 24 | $0.36 | — | ||
| Q2 24 | $-0.29 | — | ||
| Q1 24 | $-0.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $90.9M |
| Total DebtLower is stronger | $735.8M | — |
| Stockholders' EquityBook value | $1.4B | $341.7M |
| Total Assets | $12.6B | $461.5M |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | $90.9M | ||
| Q3 25 | $185.3M | $93.3M | ||
| Q2 25 | $160.4M | $75.5M | ||
| Q1 25 | $177.1M | $95.3M | ||
| Q4 24 | $167.4M | $98.7M | ||
| Q3 24 | $195.1M | $162.3M | ||
| Q2 24 | $235.5M | $177.9M | ||
| Q1 24 | $226.9M | $168.8M |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $1.4B | $341.7M | ||
| Q3 25 | $1.4B | $378.6M | ||
| Q2 25 | $1.4B | $377.6M | ||
| Q1 25 | $1.4B | $379.6M | ||
| Q4 24 | $1.4B | $395.7M | ||
| Q3 24 | $1.4B | $385.5M | ||
| Q2 24 | $1.4B | $389.1M | ||
| Q1 24 | $1.5B | $392.6M |
| Q4 25 | $12.6B | $461.5M | ||
| Q3 25 | $12.4B | $494.9M | ||
| Q2 25 | $10.6B | $493.3M | ||
| Q1 25 | $10.0B | $482.6M | ||
| Q4 24 | $9.2B | $499.5M | ||
| Q3 24 | $8.9B | $491.2M | ||
| Q2 24 | $8.2B | $483.7M | ||
| Q1 24 | $7.4B | $492.1M |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $-771.0K |
| Free Cash FlowOCF − Capex | $125.9M | $-1.8M |
| FCF MarginFCF / Revenue | 291.6% | -2.9% |
| Capex IntensityCapex / Revenue | 18.9% | 1.6% |
| Cash ConversionOCF / Net Profit | 2.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | $-771.0K | ||
| Q3 25 | $6.9M | $-3.9M | ||
| Q2 25 | $39.2M | $108.0K | ||
| Q1 25 | $25.8M | $-125.0K | ||
| Q4 24 | $14.1M | $2.0M | ||
| Q3 24 | $-922.0K | $13.2M | ||
| Q2 24 | $-993.0K | $6.2M | ||
| Q1 24 | $-13.1M | $4.0M |
| Q4 25 | $125.9M | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | $-10.6M | $1.1M | ||
| Q3 24 | $-8.6M | $12.2M | ||
| Q2 24 | $-8.6M | $5.2M | ||
| Q1 24 | $-19.1M | $3.4M |
| Q4 25 | 291.6% | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | -39.6% | 1.9% | ||
| Q3 24 | -42.3% | 23.7% | ||
| Q2 24 | -44.9% | 11.0% | ||
| Q1 24 | -107.0% | 7.6% |
| Q4 25 | 18.9% | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | 92.3% | 1.6% | ||
| Q3 24 | 37.7% | 2.0% | ||
| Q2 24 | 39.7% | 2.3% | ||
| Q1 24 | 33.5% | 1.3% |
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | -0.02× | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
